Company description From the company’s 2013 S-1: “Our proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals. The development of our current organism was originally funded by the DOE in the late 1990s, was further developed and scaled up, […]
In Minnesota, BioAmber announced it has signed an exclusive supply agreement for bio-based succinic acid with Oleon. Under the terms of the 5-year contract, which runs from 2014 to the end of 2018, BioAmber Sarnia, a joint venture with Mitsui & Co., will supply Oleon with bio-based succinic acid for the development and production of […]
In Florida, The Digest is reporting voting from the earliest precincts in the Hot 30, Hot 40 and Hot 50 ballots. These votes are based entirely to date on subscriber voting. Photo Votes are now being tallied, and the voting by the invited International Board of Selectors will begin later this month. With early precincts […]
If you get hip to this nylon tip, and take a California trip, you’ll get a kick from Genomatica’s new route to 6,6. From California, we’ve learned that Genomatica is going public with its third development program, entering into the world of biobased nylon intermediates – after its success in licensing its BDO process to […]
BioAmber’s 3-plant capacity now sold out; 210,000 tons per year, when all three plants operational. BDO deal expanded. Word arrived from Minnesota that BioAmber has signed a 210,000 ton per year take-or-pay contract for bio-based succinic acid with Vinmar International. Explaining why BioAmber stock shot up nearly 17% in today’s trading despite a global equities […]
As many technologies pivot or delay, one train keeps chugging on its route to biosuccinic acid, and markets like BDO, resins and polyols. What is it about the business model that keeps on working? What can every integrated biorefinery learn from its approach? In Minneapolis, BioAmber just announced a contract to supply a minimum of […]
As ABLC completes its second day, companies, agencies, financiers step forward to detail advances toward scale, new programs. In Washington, more than 35 companies came under the microscope as delegates at ABLC, the annual bioeconomy leadership conference which continues through Wednesday with more than 100 speakers on the agenda, moved from policy considerations to a […]
Advanced biofuels – are plans turning into reality? Are development plans realistic? When these 10 projects open for business (or not) in 2014, you’ll know for sure. We wrote in 2012: “If, by this time next year, we have all of these projects completed and in operation, it will go a long way towards substantiating […]
Company description From the company’s 2013 S-1: “Our proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals. The development of our current organism was originally funded by the DOE in the late 1990s, was further developed and scaled up, […]
In France, BioAmber announced that the French Autorité des marchés financiers approved BioAmber’s prospectus for admission of its common stock to listing and trading on the Professional Segment of NYSE Euronext Paris, and has granted visa number 13-265, dated June 10, 2013, on the prospectus. BioAmber’s common stock will commence trading on the NYSE Euronext […]
